Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 298

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 298
---
  150 |   |

<div align='center'>F-41</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 5:- | CONVERTIBLE NOTES |

| a. | During 2020, the Company                                                                                                 
 entered into various Convertible Loan Agreements (the “2020 CLAs”). As of June 30, 2025, the Company received $900 from  
 the issuance of convertible notes (the “2020 Notes”) under the 2020 CLAs. In addition, during 2024, the Company received 
 an additional $450 as part of the October 2024 CLA Addendum as described below.                                          |

The 2020 Notes bear no interest
and, unless previously converted (see below), shall become fully due and payable in cash following one (1) year from each 2020 CLA issuance
date. The 2020 Notes may be converted into the most senior securities of the Company or repaid as follows:

| 1. | Automatic conversion                                                                                                                   
 upon occurrence of a qualified round – upon the closing of a qualified round (transaction or series of related transactions            
 in which shares of the Company having substantially similar rights are issued for an aggregate investment amount of at least $ 3,000), 
 the 2020 Notes shall be automatically be converted into such number of shares of the most senior securities issued in such qualified   
 round, based on a price per share equal to 80% of the lowest price per share actually paid by any investor in the qualified round.     |

| 2. | Automatic conversion                                                                                                         
 upon occurrence of a merger and acquisition transaction – upon the closing of merger and acquisition transaction (as defined 
 in the 2020 CLAs), the 2020 Notes shall be automatically converted into Company’s most senior securities, based on a price   
 per share equal to 80% of the lowest price per attributed to such securities in the merger and acquisition transaction.      |

In October 2021, the Company and 2020
CLA investors reached an agreement according to which, in connection with the raising of the 2021 Notes, the 2020 Notes will be converted
into Ordinary Shares upon the occurrence of an exit event (including an IPO or merger) of the Company based on a price per share equal
to 80% at a